1. Market Research
  2. > Healthcare Market Trends
  3. > DOZ SA in Consumer Health (Poland)

DOZ SA in Consumer Health (Poland)

  • November 2015
  • -
  • Euromonitor International
  • -
  • 3 pages

DOZ SA belongs to the Corporation of European Pharmaceutical Distributors NV, a holding company that is responsible for the development of a retail distribution network in Europe. It is present in Poland, Lithuania, and the UK.

Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.


Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Table Of Contents

DOZ SA in Consumer Health (Poland)
DOZ SA IN CONSUMER HEALTH (POLAND)
Euromonitor International
November 2015

LIST OF CONTENTS AND TABLES

Strategic Direction
Key Facts
Summary 1 DOZ SA: Key Facts
Summary 2 DOZ SA: Operational Indicators
Competitive Positioning
Summary 3 DOZ SA: Competitive Position 2014












View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Ophthalmology Drug Development Pipeline Review, 2016

Ophthalmology Drug Development Pipeline Review, 2016

  • $ 3995
  • Company report
  • December 2016
  • by GBI Research

Ophthalmology Drug Development Pipeline Review, 2016 Summary Ophthalmology disorders are associated with the eyes and visual system. If left untreated, serious long-term co-morbidities such as diabetes, ...

Diabetes & Obesity Drug Development Pipeline Review, 2016

Diabetes & Obesity Drug Development Pipeline Review, 2016

  • $ 3995
  • Company report
  • December 2016
  • by GBI Research

Diabetes & Obesity Drug Development Pipeline Review, 2016 Summary The diabetes and obesity disease cluster is currently dominated by therapeutics indicated for type 1 diabetes mellitus (T1DM) and type ...

Peptidyl Prolyl Cis Trans Isomerase A (Cyclophilin A or Cyclosporin A Binding Protein or Rotamase A or PPIA or EC 5.2.1.8) - Pipeline Review, H2 2016

Peptidyl Prolyl Cis Trans Isomerase A (Cyclophilin A or Cyclosporin A Binding Protein or Rotamase A or PPIA or EC 5.2.1.8) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • December 2016
  • by Global Markets Direct

Peptidyl Prolyl Cis Trans Isomerase A (Cyclophilin A or Cyclosporin A Binding Protein or Rotamase A or PPIA or EC 5.2.1.8) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Peptidyl Prolyl ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.